Cargando…

Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance

INTRODUCTION: Recent evidence suggests that complement activation is important in the pathogenesis of pauci-immune (PI) vasculitis. This is a retrospective investigation of the frequency of hypocomplementemia at pauci-immune glomerulonephritis (PIGN) diagnosis, in relation to vasculitic manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lionaki, Sophia, Marinaki, Smaragdi, Liapis, George, Kalaitzakis, Emmanuel, Fragkioudaki, Sophia, Kalogeropoulos, Petros, Michelakis, Ioannis, Goules, Andreas, Tzioufas, Athanasios G., Boletis, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418949/
https://www.ncbi.nlm.nih.gov/pubmed/34514203
http://dx.doi.org/10.1016/j.ekir.2021.05.043
_version_ 1783748663218012160
author Lionaki, Sophia
Marinaki, Smaragdi
Liapis, George
Kalaitzakis, Emmanuel
Fragkioudaki, Sophia
Kalogeropoulos, Petros
Michelakis, Ioannis
Goules, Andreas
Tzioufas, Athanasios G.
Boletis, John N.
author_facet Lionaki, Sophia
Marinaki, Smaragdi
Liapis, George
Kalaitzakis, Emmanuel
Fragkioudaki, Sophia
Kalogeropoulos, Petros
Michelakis, Ioannis
Goules, Andreas
Tzioufas, Athanasios G.
Boletis, John N.
author_sort Lionaki, Sophia
collection PubMed
description INTRODUCTION: Recent evidence suggests that complement activation is important in the pathogenesis of pauci-immune (PI) vasculitis. This is a retrospective investigation of the frequency of hypocomplementemia at pauci-immune glomerulonephritis (PIGN) diagnosis, in relation to vasculitic manifestations, renal histopathology, and treatment outcomes. METHODS: A total of 115 patients with biopsy-proven PIGN were categorized based on their serum complement C3 (sC3). Histopathology evaluation included activity and chronicity indexes. The primary outcome of interest was treatment resistance, defined as a progressive decline in kidney function, with persistently active urine sediment, leading to dialysis dependency or vasculitis-related death. RESULTS: In all, 20.9% of patients had low sC3 levels associated with more advanced renal impairment (P < 0.01), requiring acute dialysis (P < 0.01) more frequently compared to patients with normal sC3. Within 1 year, 85.7% of patients with normal sC3 responded to therapy, versus 58.3% of those with low sC3 (P = 0.001). The probability of treatment resistance was strongly associated with low sC3 (P = 0.004), high serum creatinine (P < 0.001), acute dialysis requirement (P < 0.001), and high histopathological score of chronicity (P < 0.01). Advanced histopathological activity was related to more intense interstitial leukocyte infiltration (P = 0.005) and higher likelihood of fibrinoid necrosis documentation in a vessel wall (P = 0.02). The probability of treatment resistance was higher in patients with low sC3 (odds ratio [OR] = 6.47, 95% confidence interval [CI] 1.47−28.35, P = 0.013), oliguria (OR = 29.57, 95% CI = 4.74−184, P < 0.0001), and high chronicity score (OR = 1.77, 95% CI = 1.23−2.54, P = 0.002). CONCLUSION: Low sC3 is emerging as an independent predictor of treatment resistance in patients with PIGN associated with higher index of histopathological activity at diagnosis compared to normal sC3.
format Online
Article
Text
id pubmed-8418949
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84189492021-09-10 Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance Lionaki, Sophia Marinaki, Smaragdi Liapis, George Kalaitzakis, Emmanuel Fragkioudaki, Sophia Kalogeropoulos, Petros Michelakis, Ioannis Goules, Andreas Tzioufas, Athanasios G. Boletis, John N. Kidney Int Rep Clinical Research INTRODUCTION: Recent evidence suggests that complement activation is important in the pathogenesis of pauci-immune (PI) vasculitis. This is a retrospective investigation of the frequency of hypocomplementemia at pauci-immune glomerulonephritis (PIGN) diagnosis, in relation to vasculitic manifestations, renal histopathology, and treatment outcomes. METHODS: A total of 115 patients with biopsy-proven PIGN were categorized based on their serum complement C3 (sC3). Histopathology evaluation included activity and chronicity indexes. The primary outcome of interest was treatment resistance, defined as a progressive decline in kidney function, with persistently active urine sediment, leading to dialysis dependency or vasculitis-related death. RESULTS: In all, 20.9% of patients had low sC3 levels associated with more advanced renal impairment (P < 0.01), requiring acute dialysis (P < 0.01) more frequently compared to patients with normal sC3. Within 1 year, 85.7% of patients with normal sC3 responded to therapy, versus 58.3% of those with low sC3 (P = 0.001). The probability of treatment resistance was strongly associated with low sC3 (P = 0.004), high serum creatinine (P < 0.001), acute dialysis requirement (P < 0.001), and high histopathological score of chronicity (P < 0.01). Advanced histopathological activity was related to more intense interstitial leukocyte infiltration (P = 0.005) and higher likelihood of fibrinoid necrosis documentation in a vessel wall (P = 0.02). The probability of treatment resistance was higher in patients with low sC3 (odds ratio [OR] = 6.47, 95% confidence interval [CI] 1.47−28.35, P = 0.013), oliguria (OR = 29.57, 95% CI = 4.74−184, P < 0.0001), and high chronicity score (OR = 1.77, 95% CI = 1.23−2.54, P = 0.002). CONCLUSION: Low sC3 is emerging as an independent predictor of treatment resistance in patients with PIGN associated with higher index of histopathological activity at diagnosis compared to normal sC3. Elsevier 2021-06-12 /pmc/articles/PMC8418949/ /pubmed/34514203 http://dx.doi.org/10.1016/j.ekir.2021.05.043 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Lionaki, Sophia
Marinaki, Smaragdi
Liapis, George
Kalaitzakis, Emmanuel
Fragkioudaki, Sophia
Kalogeropoulos, Petros
Michelakis, Ioannis
Goules, Andreas
Tzioufas, Athanasios G.
Boletis, John N.
Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title_full Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title_fullStr Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title_full_unstemmed Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title_short Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance
title_sort hypocomplementemia at diagnosis of pauci-immune glomerulonephritis is associated with advanced histopathological activity index and high probability of treatment resistance
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418949/
https://www.ncbi.nlm.nih.gov/pubmed/34514203
http://dx.doi.org/10.1016/j.ekir.2021.05.043
work_keys_str_mv AT lionakisophia hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT marinakismaragdi hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT liapisgeorge hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT kalaitzakisemmanuel hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT fragkioudakisophia hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT kalogeropoulospetros hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT michelakisioannis hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT goulesandreas hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT tzioufasathanasiosg hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance
AT boletisjohnn hypocomplementemiaatdiagnosisofpauciimmuneglomerulonephritisisassociatedwithadvancedhistopathologicalactivityindexandhighprobabilityoftreatmentresistance